Solazyme Reports Third Quarter 2011 Results
Solazyme, Inc. has announced financial results for the third quarter ended September 30, 2011 and recent key corporate highlights. “We are making substantial progress with the commercialization of our high value…
Rogerio Manso Joins Solazyme as CCO
Solazyme, Inc. has announced that Rogerio Manso has joined the company as its Chief Commercialization Officer. Mr. Manso will lead the commercialization of Solazyme’s tailored oil platform globally…
Solazyme and Dow Form Algal Oil Alliance
South San Francisco, California-based Solazyme, Inc. has announced a joint development agreement (JDA) and a letter of intent (LOI) with The Dow Chemical Company (NYSE: DOW) to advance…
Solazyme Adds Sir Richard Branson as Strategic Investor
Solazyme, Inc. has upped the ante one more time in the race to get to scaled-up commercialization of algae products, announcing that Sir Richard Branson has personally invested in Solazyme’s Series D…
Solazyme Adds Unilever as Strategic Investor
South San Francisco, CA-based algal biotechnology company Solazyme, has announced that Unilever has joined its Series D financing round as a strategic investor. The investment by Unilever adds to…
Solazyme Raises >$50 Million in Series D Financing Round
Solazyme, Inc., the South San Francisco-based renewable oil and bioproducts company and leader in algal biotechnology, has announced that it has raised $52 million in its Series D financing round…
AIM Interview: Solazyme’s Harrison Dillon
Seven years ago two former college roommates set up shop in a Palo Alto garage, with the mission of becoming the first company to develop commercial algae-based fuel. They built their business…
